Abstract
Although aberrant methylation of key genes in the progression of colorectal neoplasia has been reported, no model-based analysis of the incremental changes through the intermediate adenoma stage has been described. In addition, the biological drivers for these methylation changes have yet to be defined. Linear mixed-effects modelling was used in this study to understand the onset and patterns of the methylation changes of SFRP2, IGF2 DMR0, H19, LINE-1 and a CpG island methylator phenotype (CIMP) marker panel, and they were correlated with DNA methyltransferase 3B (DNMT3B) levels of expression in a sample set representative of colorectal neoplastic progression.
Original language | English |
---|---|
Pages (from-to) | 499-508 |
Number of pages | 10 |
Journal | Gut |
Volume | 60 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2011 |
Keywords
- Adenocarcinoma
- Adenoma
- Aged
- Aged, 80 and over
- Colon
- Colonic Polyps
- Colorectal Neoplasms
- CpG Islands
- DNA (Cytosine-5-)-Methyltransferase
- DNA Methylation
- DNA, Neoplasm
- Disease Progression
- Female
- Humans
- Hyperplasia
- Insulin-Like Growth Factor II
- Liver Neoplasms
- Male
- Membrane Proteins
- Microsatellite Repeats
- Middle Aged
- Precancerous Conditions
- Tumor Markers, Biological